Primary cutaneous mucormycosis in a premature neonate treated conservatively with amphotericin B

Pediatr Dermatol. 2022 Jan;39(1):99-102. doi: 10.1111/pde.14879. Epub 2021 Dec 9.

Abstract

Cutaneous mucormycosis is a rare, often fatal fungal infection that most commonly affects patients with underlying immunosuppression but also can occur in premature neonates. We report the case of an extremely premature boy (<25 weeks) who developed primary cutaneous mucormycosis shortly after birth. Although surgical debridement has been a mainstay of treatment in combination with antifungal therapy, our patient was successfully treated with amphotericin B alone-the management only reported in three other cases to date. We present this case to highlight that prompt initiation of treatment with amphotericin B alone may be an appropriate alternative to surgical intervention, particularly in patients with non-angioinvasive disease who are poor surgical candidates.

Keywords: amphotericin B; conservative treatment; infant newborn diseases; mucormycosis; premature birth.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Debridement
  • Dermatomycoses* / diagnosis
  • Dermatomycoses* / drug therapy
  • Humans
  • Infant, Newborn
  • Male
  • Mucormycosis* / diagnosis
  • Mucormycosis* / drug therapy

Substances

  • Antifungal Agents
  • Amphotericin B